| UniProt ID | GNDS_HUMAN | |
|---|---|---|
| UniProt AC | Q12967 | |
| Protein Name | Ral guanine nucleotide dissociation stimulator | |
| Gene Name | RALGDS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 914 | |
| Subcellular Localization | Cytoplasm . Nucleus . Localizes mainly in the peripheral region of the cytoplasmic membrane in oocytes and in preimplantation embryos until the 8-cell stage. Between the late 1-cell and the early 2-cell stages, nuclear localization becomes stronger. | |
| Protein Description | Stimulates the dissociation of GDP from the Ras-related RalA and RalB GTPases which allows GTP binding and activation of the GTPases. Interacts and acts as an effector molecule for R-Ras, H-Ras, K-Ras, and Rap.. | |
| Protein Sequence | MVQRMWAEAAGPAGGAEPLFPGSRRSRSVWDAVRLEVGVPDSCPVVLHSFTQLDPDLPRPESSTQEIGEELINGVIYSISLRKVQLHHGGNKGQRWLGYENESALNLYETCKVRTVKAGTLEKLVEHLVPAFQGSDLSYVTIFLCTYRAFTTTQQVLDLLFKRYGRCDALTASSRYGCILPYSDEDGGPQDQLKNAISSILGTWLDQYSEDFCQPPDFPCLKQLVAYVQLNMPGSDLERRAHLLLAQLEHSEPIEAEPEALSPVPALKPTPELELALTPARAPSPVPAPAPEPEPAPTPAPGSELEVAPAPAPELQQAPEPAVGLESAPAPALELEPAPEQDPAPSQTLELEPAPAPVPSLQPSWPSPVVAENGLSEEKPHLLVFPPDLVAEQFTLMDAELFKKVVPYHCLGSIWSQRDKKGKEHLAPTIRATVTQFNSVANCVITTCLGNRSTKAPDRARVVEHWIEVARECRILKNFSSLYAILSALQSNSIHRLKKTWEDVSRDSFRIFQKLSEIFSDENNYSLSRELLIKEGTSKFATLEMNPKRAQKRPKETGIIQGTVPYLGTFLTDLVMLDTAMKDYLYGRLINFEKRRKEFEVIAQIKLLQSACNNYSIAPDEQFGAWFRAVERLSETESYNLSCELEPPSESASNTLRTKKNTAIVKRWSDRQAPSTELSTSGSSHSKSCDQLRCGPYLSSGDIADALSVHSAGSSSSDVEEINISFVPESPDGQEKKFWESASQSSPETSGISSASSSTSSSSASTTPVAATRTHKRSVSGLCNSSSALPLYNQQVGDCCIIRVSLDVDNGNMYKSILVTSQDKAPAVIRKAMDKHNLEEEEPEDYELLQILSDDRKLKIPENANVFYAMNSTANYDFVLKKRTFTKGVKVKHGASSTLPRMKQKGLKIAKGIF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 (in isoform 3) | Phosphorylation | - | 6.29 | 24043423 | |
| 8 (in isoform 3) | Phosphorylation | - | 24.44 | 24043423 | |
| 9 (in isoform 3) | Phosphorylation | - | 15.24 | 24043423 | |
| 22 (in isoform 3) | Phosphorylation | - | 26.84 | 24043423 | |
| 23 (in isoform 3) | Phosphorylation | - | 25.43 | 24043423 | |
| 25 (in isoform 3) | Phosphorylation | - | 37.81 | 24043423 | |
| 28 (in isoform 5) | Phosphorylation | - | 28.89 | 22617229 | |
| 62 | Phosphorylation | PDLPRPESSTQEIGE CCCCCCCCCHHHHHH | 41.17 | 30206219 | |
| 63 | Phosphorylation | DLPRPESSTQEIGEE CCCCCCCCHHHHHHH | 32.23 | 30206219 | |
| 64 | Phosphorylation | LPRPESSTQEIGEEL CCCCCCCHHHHHHHH | 39.23 | 30206219 | |
| 77 | Phosphorylation | ELINGVIYSISLRKV HHHHHHHEEEEEEEE | 9.50 | 30206219 | |
| 78 | Phosphorylation | LINGVIYSISLRKVQ HHHHHHEEEEEEEEE | 8.45 | 29496963 | |
| 80 | Phosphorylation | NGVIYSISLRKVQLH HHHHEEEEEEEEEEE | 19.04 | 30206219 | |
| 480 | Phosphorylation | CRILKNFSSLYAILS CHHHCCHHHHHHHHH | 28.91 | 24043423 | |
| 481 | Phosphorylation | RILKNFSSLYAILSA HHHCCHHHHHHHHHH | 22.66 | 24043423 | |
| 483 | Phosphorylation | LKNFSSLYAILSALQ HCCHHHHHHHHHHHH | 8.11 | 24043423 | |
| 487 | Phosphorylation | SSLYAILSALQSNSI HHHHHHHHHHHHCCH | 22.33 | 24043423 | |
| 491 | Phosphorylation | AILSALQSNSIHRLK HHHHHHHHCCHHHHH | 33.13 | 24043423 | |
| 493 | Phosphorylation | LSALQSNSIHRLKKT HHHHHHCCHHHHHHH | 25.64 | 24043423 | |
| 542 | O-linked_Glycosylation | EGTSKFATLEMNPKR CCCCCCEEEECCHHH | 26.78 | 30379171 | |
| 542 | Phosphorylation | EGTSKFATLEMNPKR CCCCCCEEEECCHHH | 26.78 | 23312004 | |
| 584 | Phosphorylation | LDTAMKDYLYGRLIN HHHHHHHHHHHHHCC | 9.05 | - | |
| 586 | Phosphorylation | TAMKDYLYGRLINFE HHHHHHHHHHHCCHH | 8.25 | 17924679 | |
| 659 | Acetylation | ASNTLRTKKNTAIVK CCCCCCCCCCCHHHC | 37.28 | 7933633 | |
| 669 | Phosphorylation | TAIVKRWSDRQAPST CHHHCCCCCCCCCCC | 27.27 | 25159151 | |
| 741 | Phosphorylation | QEKKFWESASQSSPE CCHHHHHHHCCCCCC | 24.66 | - | |
| 745 | Phosphorylation | FWESASQSSPETSGI HHHHHCCCCCCCCCC | 45.42 | - | |
| 753 | Phosphorylation | SPETSGISSASSSTS CCCCCCCCCCCCCCC | 24.31 | - | |
| 767 | Phosphorylation | SSSSASTTPVAATRT CCCCCCCCCCCCCCC | 17.17 | - | |
| 778 | Phosphorylation | ATRTHKRSVSGLCNS CCCCCCCCHHHCCCC | 25.99 | 27251275 | |
| 780 | Phosphorylation | RTHKRSVSGLCNSSS CCCCCCHHHCCCCCC | 27.56 | 24719451 | |
| 785 | Phosphorylation | SVSGLCNSSSALPLY CHHHCCCCCCCCCCC | 25.36 | 23898821 | |
| 793 (in isoform 2) | Phosphorylation | - | 33.23 | 22210691 | |
| 800 (in isoform 2) | Phosphorylation | - | 3.27 | 22210691 | |
| 802 (in isoform 2) | Phosphorylation | - | 1.91 | 22210691 | |
| 815 | Acetylation | VDNGNMYKSILVTSQ CCCCCEEEEEEEECC | 21.91 | 7706951 | |
| 816 | Phosphorylation | DNGNMYKSILVTSQD CCCCEEEEEEEECCC | 12.03 | - | |
| 820 | Phosphorylation | MYKSILVTSQDKAPA EEEEEEEECCCCHHH | 19.75 | - | |
| 821 | Phosphorylation | YKSILVTSQDKAPAV EEEEEEECCCCHHHH | 28.98 | 21815630 | |
| 890 | Acetylation | RTFTKGVKVKHGASS CEECCCCEEECCCCC | 54.99 | 7974691 | |
| 892 | Acetylation | FTKGVKVKHGASSTL ECCCCEEECCCCCCH | 30.51 | 7974701 | |
| 896 | Phosphorylation | VKVKHGASSTLPRMK CEEECCCCCCHHHHH | 28.57 | 26699800 | |
| 897 | Phosphorylation | KVKHGASSTLPRMKQ EEECCCCCCHHHHHH | 33.17 | 26699800 | |
| 898 | Phosphorylation | VKHGASSTLPRMKQK EECCCCCCHHHHHHH | 37.98 | 26699800 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GNDS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GNDS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GNDS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RASM_HUMAN | MRAS | physical | 10498616 | |
| ARRB2_HUMAN | ARRB2 | physical | 12105416 | |
| ARRB1_HUMAN | ARRB1 | physical | 12105416 | |
| RASH_HUMAN | HRAS | physical | 7972015 | |
| RAP2B_HUMAN | RAP2B | physical | 10085114 | |
| RAP2A_HUMAN | RAP2A | physical | 10085114 | |
| RAP1A_HUMAN | RAP1A | physical | 10085114 | |
| RASH_HUMAN | HRAS | physical | 9038168 | |
| RRAS_HUMAN | RRAS | physical | 7809086 | |
| RASH_HUMAN | HRAS | physical | 7809086 | |
| RASK_HUMAN | KRAS | physical | 7809086 | |
| RPGF2_HUMAN | RAPGEF2 | physical | 7809086 | |
| RASH_HUMAN | HRAS | physical | 9150145 | |
| CASP8_HUMAN | CASP8 | physical | 21525013 | |
| FADD_HUMAN | FADD | physical | 21525013 | |
| RAP1B_HUMAN | RAP1B | physical | 21988832 | |
| RRAS2_HUMAN | RRAS2 | physical | 21988832 | |
| RAP1A_HUMAN | RAP1A | physical | 11786539 | |
| RAP2A_HUMAN | RAP2A | physical | 11786539 | |
| RAP2B_HUMAN | RAP2B | physical | 11786539 | |
| RASH_HUMAN | HRAS | physical | 11786539 | |
| CNKR1_HUMAN | CNKSR1 | physical | 14749388 | |
| RASH_HUMAN | HRAS | physical | 25241761 | |
| RAP2A_HUMAN | RAP2A | physical | 28405688 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-586, AND MASSSPECTROMETRY. | |